A randomized phase 2 trial of low dose (6 mg daily) versus high dose (30 mg daily) estradiol for patients with estrogen receptor positive aromatase inhibitor resistant advanced breast cancer Meeting Abstract


Authors: Ellis, M. J.; Dehdahti, F.; Kommareddy, A.; Jamalabadi-Majidi, S.; Crowder, R.; Jeffe, D. B.; Gao, F.; Fleming, G.; Silverman, P.; Dickler, M.; Carey, L.; Marcom, P. K.
Abstract Title: A randomized phase 2 trial of low dose (6 mg daily) versus high dose (30 mg daily) estradiol for patients with estrogen receptor positive aromatase inhibitor resistant advanced breast cancer
Meeting Title: 31st Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 69
Issue: 2 Suppl.
Meeting Dates: 2008 Dec 10-14
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2009-01-01
Start Page: 67S
End Page: 68S
Language: English
ACCESSION: ISI:000262583200024
PROVIDER: wos
DOI: 10.1158/0008-5472.SABCS-16
Notes: --- - Meeting Abstract: 16 - Suppl. S - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maura N Dickler
    263 Dickler